Modulation of monocyte/macrophage function: A therapeutic strategy in the treatment of acute liver failure

Journal of Hepatology

Volumn 61, Issue 2, 2014, Pages 439-445

  Possamai, Lucia A ^a   Thursz, Mark R ^a   Wendon, Julia A ^b   Antoniades, Charalambos Gustav ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acute liver failure; Biomarkers; Macrophage; Monocyte; Plasticity

Indexed keywords

ALPHA FETOPROTEIN; AMMONIA; BIOLOGICAL MARKER; CD163 ANTIGEN; CYTOKERATIN 18; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA 122; NEOPTERIN; PARACETAMOL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LIVER FAILURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MARKER; HEMATOPOIESIS; HUMAN; HYPERPHOSPHATEMIA; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; IMMUNOTHERAPY; INNATE IMMUNITY; INTRACRANIAL HYPERTENSION; KUPFFER CELL; LIVER CELL; LIVER REGENERATION; LIVER TOXICITY; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MACROPHAGE PLASTICITY; MICROGLIA; MONOCYTE; MONOCYTE FUNCTION; PHENOTYPE; PLASMAPHERESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; CELL POLARITY; IMMUNOLOGY; LIVER FAILURE, ACUTE; PHYSIOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; CELL POLARITY; CELLULAR MICROENVIRONMENT; HUMANS; IMMUNITY, INNATE; LIVER FAILURE, ACUTE; LIVER REGENERATION; MACROPHAGES; MONOCYTES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84904730520     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.03.031     Document Type: Note

References (48)

1. W. Bernal, A. Hyyrylainen, A. Gera, V.K. Audimoolam, M.J. McPhail, and G. Auzinger et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients J Hepatol 59 2013 74 80
2. C.G. Antoniades, A. Quaglia, L.S. Taams, R.R. Mitry, M. Hussain, and R. Abeles et al. Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans Hepatology 56 2012 735 746
3. N. Rolando, J. Wade, M. Davalos, J. Wendon, J. Philpott-Howard, and R. Williams The systemic inflammatory response syndrome in acute liver failure Hepatology 32 2000 734 739
4. J. Vaquero, J. Polson, C. Chung, I. Helenowski, F.V. Schiodt, and J. Reisch et al. Infection and the progression of hepatic encephalopathy in acute liver failure Gastroenterology 125 2003 755 764
5. L.C. Davies, S.J. Jenkins, J.E. Allen, and P.R. Taylor Tissue-resident macrophages Nat Immunol 14 2013 986 995
6. P. Ramachandran, A. Pellicoro, M.A. Vernon, L. Boulter, R.L. Aucott, and A. Ali et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis Proc Natl Acad Sci U S A 109 2012 E3186 E3195
7. A. Sica, P. Invernizzi, and A. Mantovani Macrophage plasticity and polarization in liver homeostasis and pathology Hepatology 59 2014 2034 2042
8. R.D. Stout, C. Jiang, B. Matta, I. Tietzel, S.K. Watkins, and J. Suttles Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences J Immunol 175 2005 342 349
9. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J Clin Invest 122 2012 787 795
10. Q. Yang, Y. Liu, Y. Shi, M. Zheng, J. He, and Z. Chen The role of intracellular high-mobility group box 1 in the early activation of Kupffer cells and the development of Con A-induced acute liver failure Immunobiology 218 2013 1284 1292
11. M.P. Holt, L. Cheng, and C. Ju Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury J Leukoc Biol 84 2008 1410 1421
12. D.L. Laskin, C.R. Gardner, V.F. Price, and D.J. Jollow Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen Hepatology 21 1995 1045 1050
13. D.M. Dambach, L.M. Watson, K.R. Gray, S.K. Durham, and D.L. Laskin Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse Hepatology 35 2002 1093 1103
14. C. Ju, T.P. Reilly, M. Bourdi, M.F. Radonovich, J.N. Brady, and J.W. George et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice Chem Res Toxicol 15 2002 1504 1513
15. Q. You, M. Holt, H. Yin, G. Li, C.J. Hu, and C. Ju Role of hepatic resident and infiltrating macrophages in liver repair after acute injury Biochem Pharmacol 86 2013 836 843
16. L. Arnold, A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, and A. Plonquet et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis J Exp Med 204 2007 1057 1069
17. M. Nahrendorf, F.K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, and J.L. Figueiredo et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions J Exp Med 204 2007 3037 3047
18. M.H. Sieweke, and J.E. Allen Beyond stem cells: self-renewal of differentiated macrophages Science 342 2013 1242974
19. R.C. Bone, R.A. Balk, F.B. Cerra, R.P. Dellinger, A.M. Fein, and W.A. Knaus et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1992 1644 1655
20. Y. Miyake, T. Yasunaka, F. Ikeda, A. Takaki, K. Nouso, and K. Yamamoto SIRS score reflects clinical features of non-acetaminophen-related acute liver failure with hepatic coma Intern Med 51 2012 823 828
21. J.A. Leithead, J.W. Ferguson, C.M. Bates, J.S. Davidson, A. Lee, and A.J. Bathgate et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure Gut 58 2009 443 449
22. L.E. Schmidt, and F.S. Larsen Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure Crit Care Med 34 2006 337 343
23. R.F. Butterworth The liver-brain axis in liver failure: neuroinflammation and encephalopathy Nat Rev Gastroenterol Hepatol 10 2013 522 528
24. D.L. Shawcross, S.S. Shabbir, N.J. Taylor, and R.D. Hughes Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis Hepatology 51 2010 1062 1069
25. C. Antoniades, P. Berry, J. Wendon, and D. Vergani The importance of immune dysfunction in determining outcome in acute liver failure J Hepatol 49 2008 845 861
26. P.A. Berry, C.G. Antoniades, M.J. Hussain, M.J. McPhail, W. Bernal, and D. Vergani et al. Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis Liver Int 30 2010 733 740
27. C.G. Antoniades, W. Khamri, R.D. Abeles, L.S. Taams, E. Triantafyllou, and L.A. Possamai et al. Secretory leukocyte protease inhibitor: A pivotal mediator of anti-inflammatory responses in acetaminophen induced acute liver failure Hepatology 59 2014 1564 1576
28. C.G. Antoniades, P.A. Berry, E.T. Davies, M. Hussain, W. Bernal, and D. Vergani et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure Hepatology 44 2006 34 43
29. D.J. Antoine, R.E. Jenkins, J.W. Dear, D.P. Williams, M.R. McGill, and M.R. Sharpe et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity J Hepatol 56 2012 1070 1079
30. L.A. Possamai, M.J. McPhail, A. Quaglia, V. Zingarelli, R.D. Abeles, and R. Tidswell et al. Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure Crit Care Med 41 2013 2543 2550
31. P.J. Starkey Lewis, J. Dear, V. Platt, K.J. Simpson, D.G. Craig, and D.J. Antoine et al. Circulating microRNAs as potential markers of human drug-induced liver injury Hepatology 54 2011 1767 1776
32. D.G. Craig, P. Lee, E.A. Pryde, P.C. Hayes, and K.J. Simpson Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)-induced human acute liver injury Aliment Pharmacol Ther 38 2013 1395 1404
33. H.J. Moller, H. Gronbaek, F.V. Schiodt, P. Holland-Fischer, M. Schilsky, and S. Munoz et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure J Hepatol 47 2007 671 676
34. D.J. Antoine, D.P. Williams, A. Kipar, R.E. Jenkins, S.L. Regan, and J.G. Sathish et al. High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo Toxicol Sci 112 2009 521 531
35. L.E. Schmidt, and K. Dalhoff Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury Hepatology 41 2005 26 31
36. F.V. Schiodt, G. Ostapowicz, N. Murray, R. Satyanarana, A. Zaman, and S. Munoz et al. Alpha-fetoprotein and prognosis in acute liver failure Liver Transpl 12 2006 1776 1781
37. L.E. Schmidt, and K. Dalhoff Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity Hepatology 36 2002 659 665
38. K.A. Cavassani, A.P. Moreira, D. Habiel, T. Ito, A.L. Coelho, and R.M. Allen et al. Toll like receptor 3 plays a critical role in the progression and severity of acetaminophen-induced hepatotoxicity PLoS One 8 2013 e65899
39. A. Moles, L. Murphy, C.L. Wilson, J.B. Chakraborty, C. Fox, and E.J. Park et al. A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse J Hepatol 60 2014 782 791
40. X. Wang, R. Sun, H. Wei, and Z. Tian High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: interaction of gammadelta T cells with macrophages Hepatology 57 2013 373 384
41. J. Karkhanis, E.C. Verna, M.S. Chang, R.T. Stravitz, M. Schilsky, and W.M. Lee et al. Steroid use in acute liver failure Hepatology 59 2014 612 621
42. K. Kotoh, M. Enjoji, M. Nakamuta, T. Yoshimoto, M. Kohjima, and S. Morizono et al. Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure World J Gastroenterol 12 2006 6678 6682
43. C. Di Campli, M.A. Zocco, R. Gaspari, M. Novi, M. Candelli, and A. Santoliquido et al. The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure Transplant Proc 37 2005 2551 2553
44. M. Rocen, E. Kieslichova, D. Merta, E. Uchytilova, Y. Pavlova, and J. Cap et al. The effect of Prometheus device on laboratory markers of inflammation and tissue regeneration in acute liver failure management Transplant Proc 42 2010 3606 3611
45. I. Ilonen, A.M. Koivusalo, K. Hockerstedt, and H. Isoniemi Albumin dialysis has no clear effect on cytokine levels in patients with life-threatening liver insufficiency Transplant Proc 38 2006 3540 3543
46. S. Sen, N.A. Davies, R.P. Mookerjee, L.M. Cheshire, S.J. Hodges, and R. Williams et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study Liver Transpl 10 2004 1109 1119
47. F.S. Larsen, L.E. Schmidt, J. Wendon, K. Hockerstedt, H. Isoniemi, and W. Bernal Liver assisting with high volume plasma exchange in patients with acute liver failure Hepatology 52 2010 376A
48. F.S. Larsen, B.A. Hansen, E. Ejlersen, N.H. Secher, J.O. Clemmesen, and N. Tygstrup et al. Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure Eur J Gastroenterol Hepatol 8 1996 261 265